Low-Cost Gait Analysis Technologies for Clinical and Real-World Assessment: A Scoping Review of Validity, Reliability, and Clinical Utility

Walking is the most fundamental human movement, a rhythm so automatic we rarely think about the mechanics of it until something goes wrong. For doctors and therapists, however, understanding exactly how a person walks is a critical tool. It helps them diagnose neurological conditions, plan treatments for injuries, and track whether a patient is truly recovering. For decades, the gold standard for this analysis has been the gait laboratory: a specialized room filled with high-speed cameras, force-sensitive floors, and complex computer systems that map every joint angle and foot pressure. While these labs provide incredibly detailed data, they are expensive, require a team of experts to operate, and are often locked away in research centers, leaving most clinics and patients without access to objective measurements.

In recent years, a new wave of technology has promised to bring this level of analysis out of the lab and into the real world. These are low-cost tools: wearable sensors that clip onto shoes or ankles, smartphone apps that record movement, and video systems that can track a person without attaching any markers to their skin. The hope has been that these affordable devices could replace the giant machines, allowing doctors to assess gait in a regular clinic, a community center, or even a patient's home. But as these technologies have multiplied, a question has lingered: do they actually work well enough to be trusted for medical decisions, or are they just interesting gadgets?

A comprehensive review conducted by researchers from universities in Nigeria and the United Kingdom set out to answer this question by examining the entire body of evidence available. They gathered and analyzed 120 scientific studies published between 1995 and 2026, looking at everything from wearable sensors to video-based systems. Their goal was not just to see if these devices could measure walking, but to determine if the measurements were accurate, consistent, and useful enough for real-world medical care. They looked for proof that the devices could detect small changes in a patient's condition, that they were affordable to set up completely, and that they had been tested in the actual environments where they would be used.

The researchers found a landscape rich in technical promise but thin on practical proof. The vast majority of the studies they reviewed focused on testing the devices in controlled laboratory settings, often with healthy adults walking on a treadmill. While these studies showed that many low-cost systems could generate data that looked similar to the expensive lab equipment, the evidence for their use in real clinical situations was surprisingly scarce. Out of the 120 studies, only five directly tested whether the technology actually helped a clinician make a better decision or improved patient care. Most studies simply reported that the devices worked in a lab, without proving they could handle the messiness of a busy hospital or a patient's living room.

A significant gap emerged regarding the reliability of the data. Many studies claimed the devices were accurate because their results matched the lab equipment closely, but the researchers noted that matching results does not always mean the devices are interchangeable. A device might show a consistent pattern of movement without being precise enough to detect the small improvements a patient makes after a week of therapy. Furthermore, the review found that very few studies reported the total cost of using these systems. While a single sensor might be cheap, the review highlighted that the full setup often requires specific computers, software subscriptions, and accessories that were rarely included in the price tags researchers reported. Only one study in the entire review explicitly confirmed that a complete, working system could be built for under one thousand US dollars.

The geographic distribution of the research also revealed a major blind spot. None of the 120 studies were conducted primarily in Africa, despite the continent having some of the greatest needs for accessible rehabilitation services. The evidence was heavily concentrated in Europe and North America, meaning the findings might not apply to settings with different infrastructure, power supplies, or healthcare systems. This lack of local data makes it difficult to know if these "low-cost" solutions are truly affordable or usable in the places where they are needed most.

Ultimately, the review concludes that while low-cost gait technologies are technically capable of measuring walking, the evidence is not yet strong enough to support their unrestricted use in clinical practice. The researchers argue that we cannot assume a device is ready for the clinic just because it is portable or because it shows a high correlation with lab data. True readiness requires proof that the device is affordable as a complete package, that it can detect meaningful changes in a patient's health, and that it works reliably in the specific environment where it will be used. Until more studies provide this kind of direct evidence, particularly in diverse global settings, these tools remain promising but unproven for widespread medical adoption. The path forward, the authors suggest, is to move beyond simple technical testing and focus on rigorous trials that prove these technologies can genuinely improve patient care in the real world.